Search Browse Earnings

RxSight, Inc. — SlamSEC

RxSight, Inc.

Nasdaq:RXST

Ophthalmic Goods·ALISO VIEJO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$89.1M

+81.8% YoY

FY 2025

Adj. EBITDA

-$46.0M

-51.6% margin

FY 2025

Net Income

-$48.6M

-54.6% margin

FY 2025

EPS (Diluted)

-$1.41

FY 2025

Stock Price

$7.64

+3.4%

2026-03-12

52W Range

$6.32 – $27.13

P/E Ratio

-5.4x

Market Cap

$315.3M

Cash

$16.7M

FY 2025

Total Debt

$40.2M

FY 2023

Net Debt

$23.5M

FY 2023

Enterprise Value

$338.7M

Debt / EBITDA

-0.5x

FY 2025

EV / EBITDA

-7.4x

Employees

—